Dr. Layla Barrera, DO
NPI: 1447788575
Total Payments
$932.93
2024 Payments
$110.77
Companies
18
Transactions
47
Medicare Patients
627
Medicare Billing
$71,246
Payment Breakdown by Category
Food & Beverage$932.93 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $932.93 | 47 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $136.14 | 7 | $0 (2023) |
| Merck Sharp & Dohme LLC | $101.14 | 6 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $94.02 | 4 | $0 (2024) |
| Amarin Pharma Inc. | $84.83 | 4 | $0 (2022) |
| Amgen Inc. | $72.90 | 3 | $0 (2023) |
| Daiichi Sankyo Inc. | $71.92 | 4 | $0 (2023) |
| ABBVIE INC. | $69.88 | 4 | $0 (2024) |
| Lilly USA, LLC | $68.59 | 3 | $0 (2023) |
| Kowa Pharmaceuticals America, Inc. | $35.02 | 2 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $32.46 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $110.77 | 5 | ABBVIE INC. ($57.52) |
| 2023 | $228.40 | 11 | GlaxoSmithKline, LLC. ($37.58) |
| 2022 | $392.16 | 20 | Merck Sharp & Dohme LLC ($70.22) |
| 2021 | $201.60 | 11 | Amarin Pharma Inc. ($41.64) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/15/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/16/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/03/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: DIABETES | ||||||
| 01/25/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/27/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Diabetes | ||||||
| 04/20/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Hematology | ||||||
| 03/27/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Diabetes | ||||||
| 03/23/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/14/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: RESPIRATORY | ||||||
| 03/01/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Oncology | ||||||
| 02/16/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: RESPIRATORY | ||||||
| 01/31/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.01 | General |
| 01/26/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: Inflammation | ||||||
| 01/24/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: VACCINES | ||||||
| 01/19/2023 | Merck Sharp & Dohme LLC | PNEUMOVAX 23 (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: VACCINE | ||||||
| 12/20/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/17/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Inflammation | ||||||
| 10/27/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: RESPIRATORY | ||||||
| 10/13/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: VACCINE | ||||||
| 10/11/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Cardiovascular | ||||||
| 10/06/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/22/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV | Food and Beverage | In-kind items and services | $25.42 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 153 | 224 | $94,751 | $21,342 |
| 2022 | 6 | 202 | 270 | $87,827 | $21,435 |
| 2021 | 7 | 202 | 288 | $74,743 | $19,523 |
| 2020 | 3 | 70 | 91 | $34,118 | $8,946 |
Total Patients
627
Total Services
873
Medicare Billing
$71,246
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 127 | 191 | $84,422 | $19,182 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 33 | $10,329 | $2,160 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 145 | $64,670 | $15,275 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 52 | $16,640 | $3,825 | 23.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 19 | 19 | $3,800 | $1,335 | 35.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 22 | 22 | $1,870 | $776.38 | 41.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 13 | $676.00 | $167.72 | 24.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 18 | 19 | $171.00 | $56.28 | 32.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 108 | $47,412 | $12,005 | 25.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 70 | $21,770 | $5,718 | 26.3% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 11 | 11 | $2,030 | $725.30 | 35.7% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 25 | 25 | $1,275 | $509.50 | 40.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $1,105 | $264.31 | 23.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 13 | 14 | $728.00 | $161.26 | 22.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 35 | 47 | $423.00 | $139.37 | 32.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 31 | 35 | $13,650 | $3,527 | 25.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 21 | 26 | $12,818 | $3,412 | 26.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 18 | 30 | $7,650 | $2,007 | 26.2% |
About Dr. Layla Barrera, DO
Dr. Layla Barrera, DO is a Student in an Organized Health Care Education/Training Program healthcare provider based in Stony Brook, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2017. The National Provider Identifier (NPI) number assigned to this provider is 1447788575.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Layla Barrera, DO has received a total of $932.93 in payments from pharmaceutical and medical device companies, with $110.77 received in 2024. These payments were reported across 47 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($932.93).
As a Medicare-enrolled provider, Barrera has provided services to 627 Medicare beneficiaries, totaling 873 services with total Medicare billing of $71,246. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Stony Brook, NY
- Active Since 06/02/2017
- Last Updated 04/08/2024
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1447788575
Products in Payments
- TRELEGY ELLIPTA (Drug) $116.10
- Vascepa (Drug) $84.83
- Otezla (Drug) $72.90
- INJECTAFER (Drug) $71.92
- GARDASIL 9 (Biological) $51.75
- DALVANCE (Drug) $35.25
- Livalo (Drug) $35.02
- LEQVIO (Drug) $32.46
- BELSOMRA (Drug) $31.47
- JARDIANCE (Drug) $28.08
- EMGALITY (Drug) $26.27
- XARELTO (Drug) $25.17
- TRULICITY (Drug) $24.89
- Cologuard Collection Kit (Device) $22.75
- Mitigare (Drug) $22.27
- TEFLARO (Drug) $22.27
- ACCRUFER (Drug) $21.62
- Ozempic (Drug) $20.67
- ANORO ELLIPTA (Drug) $20.04
- IFUSE IMPLANT (Device) $19.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Stony Brook
Noreen Bukhari-Parlakturk, Md, Phd, MD, PHD
Student in an Organized Health Care Education/Training Program — Payments: $26,258
Student in an Organized Health Care Education/Training Program $26,258
Aadit Shah, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $18,802
Student in an Organized Health Care Education/Training Program $18,802
Kristine Jang, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $18,437
Student in an Organized Health Care Education/Training Program $18,437
Mr. Stuart Drew
Student in an Organized Health Care Education/Training Program — Payments: $10,662
Student in an Organized Health Care Education/Training Program $10,662
Dr. Brian Mccormack, Dds, DDS
Student in an Organized Health Care Education/Training Program — Payments: $9,541
Student in an Organized Health Care Education/Training Program $9,541
Sonya Marcus, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $8,616
Student in an Organized Health Care Education/Training Program $8,616